Skip to content

Diaphragmatic Breathing Training on Postpartum Anxiety

Effects of A Biofeedback-assisted Diaphragmatic Breathing Training on Postpartum Anxiety: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05474248
Enrollment
128
Registered
2022-07-26
Start date
2021-02-28
Completion date
2022-12-31
Last updated
2022-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Anxiety

Keywords

postpartum anxiety, biofeedback, diaphragmatic breathing

Brief summary

This is a two-group pretest-posttest, triple-blinded and randomized controlled trial examining the effects of a biofeedback-assisted diaphragmatic breathing training on postpartum anxiety. This study will include full-term postpartum women, aged from 20 to 49, who experienced anxious symptoms with State Anxiety Inventory (A-State) scored 40 or more at the first postpartum day. Participants will be randomly assigned to either an experimental group (n = 64) or a control group (n = 64). The experimental group will undergo the diaphragmatic breathing training assisted with StressEraser to breath slowly 4-6 times per minute and practice 15 minutes twice daily. Participants in the control condition receive postpartum usual care. The outcome measures include anxiety measured by State-Trait Anxiety Inventory (STAI) and the physiological parameters expressed by blood pressure (BP) and heart rate (HR). Measurements will be taken at the first postpartum day and one month postpartum. We except this breathing training design is able to improve women's postpartum anxiety, and in turn improve their physio-psychological health, breastfeeding and baby care skills.

Detailed description

Ditto

Interventions

BEHAVIORALExperimental group

Diaphragmatic Breathing Training

Sponsors

Taichung Tzu Chi Hospital
CollaboratorOTHER
Ministry of Science and Technology, Taiwan
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* full-term postpartum women * aged from 20 to 49 * STAI-S scored 40 or more at the first postpartum day

Exclusion criteria

* newborn with severe illness or stillbirth * maternal suicide or self-harm * drug use: sedatives, hypnotics or antipsychotic drugs

Design outcomes

Primary

MeasureTime frameDescription
Postpartum anxietyBaseline: postpartum day 1-3Assessments using the State-Trait Anxiety Inventory-State (STAI-S) for self-reported anxiety symptoms

Secondary

MeasureTime frameDescription
Heart rateBaseline: postpartum day 1-3Assessments using A&D sphygmomanometer (Model 767Plus, A&D Co., LTD., Japan) for heart rate
Blood pressureBaseline: postpartum day 1-3Assessments using A&D sphygmomanometer (Model 767Plus, A&D Co., LTD., Japan) for systolic blood pressure and diastolic blood pressure

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026